Business Standard

Jubilant Life Sciences surges 12% on robust March quarter earnings

Reacting to its earnings, the stock advanced as much as 12.5% to Rs 762 on the BSE

Jubilant Life Sciences
Premium

Jubilant Life Sciences

SI Reporter New Delhi
Shares of Jubilant Life Sciences surged over 12% in trade on Wednesday after the company's consolidated net profit zoomed nearly 14-fold to Rs 149.03 crore in the March quarter on robust sales.

The company had posted a net profit of Rs 10.86 crore for the corresponding period of the previous fiscal year.

Reacting to its earnings, the stock advanced as much as 12.5% to Rs 762 on the BSE. 

Over 3 lakh shares of the scrip exchanged hands on the BSE so far against its two-week average of 50,000 shares. 

The company's consolidated total revenue from operations rose to Rs 1,641.42 crore for the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in